EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Novel PSEN1 ( Q223 L ) mutation causes early-onset Alzheimer’s disease: A case report

Jie Li, Fen-Li Zhou, Juan-Juan Chen, Zhi-Jian Lin, Xin Shi, Guo-Gao Zhang, Hong-Jie Yang, Meng-Jie Dong, Li Yi, Jun Hu, Xu-Hui Chen

World Journal of Radiology · 28.06.2026 · 18 (6)

DOI: 10.4329/wjr.116652 ↗

Kurz gefasst

Fallbericht in der Zeitschrift World Journal of Radiology, online erschienen am 28.06.2026. Verfasst von Jie Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Mutations in the PSEN1 , PSEN2 , and APP genes are known to cause Alzheimer’s disease (AD). Among these, PSEN1 mutations are the most frequent causes of autosomal dominant early-onset AD (EOAD). Patients harboring pathogenic mutations often exhibit considerable clinical heterogeneity. Identifying novel mutations and analyzing their associations with clinical cases is crucial for advancing our understanding of the pathogenesis of AD. CASE SUMMARY This report describes the clinical presentation of a family with EOAD. The proband was a 43-year-old Chinese female who presented with a three-year history of cognitive decline for 3 years. Magnetic resonance imaging demonstrated diffuse cerebral cortical atrophy. Next-generation sequencing identified a novel heterozygous c.668A>T mutation in PSEN1 , which resulted in a p.Gln223 Leu. cerebrospinal fluid biomarker analysis revealed abnormal levels of amyloid and tau, indicative of underlying Alzheimer’s pathology. Furthermore, 18F-flortaucipir (AV-1451) positron emission topography and 18F-florbetapir (AV-45) positron emission topography imaging demonstrated extensive cerebral amyloid beta and tau deposition. CONCLUSION We report a novel pathogenic PSEN1 mutation, Q223 L , identified for the first time in a Chinese family with EOAD.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseCase reportGeneMutationPSEN1Pathogenic

Autor:innen und Institutionen

  • Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.
  • Shenzhen Key Laboratory for Neuronal Structural Biology, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, Guangdong Province, China.
  • Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.
  • Shenzhen Key Laboratory for Neuronal Structural Biology, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, Guangdong Province, China. xuhuichen@pkuszh.com.

Zitieren

APA

Li, J., Zhou, F. L., Chen, J. J., Lin, Z. J., Shi, X., Zhang, G. G., Yang, H. J., Dong, M. J., Yi, L., Hu, J., & Chen, X. H. (2026). Novel PSEN1 ( Q223 L ) mutation causes early-onset Alzheimer’s disease: A case report. World Journal of Radiology, 18(6). https://doi.org/10.4329/wjr.116652

Vancouver

Li J, Zhou FL, Chen JJ, Lin ZJ, Shi X, Zhang GG, et al. Novel PSEN1 ( Q223 L ) mutation causes early-onset Alzheimer’s disease: A case report. World Journal of Radiology. 2026;18(6). doi:10.4329/wjr.116652

BibTeX
@article{Li2026,
  author = {Li, Jie and Zhou, Fen-Li and Chen, Juan-Juan and Lin, Zhi-Jian and Shi, Xin and Zhang, Guo-Gao and Yang, Hong-Jie and Dong, Meng-Jie and Yi, Li and Hu, Jun and Chen, Xu-Hui},
  title = {Novel PSEN1 ( Q223 L ) mutation causes early-onset Alzheimer’s disease: A case report},
  journal = {World Journal of Radiology},
  year = {2026},
  volume = {18},
  number = {6},
  doi = {10.4329/wjr.116652}
}
Kostenlos starten →